An Open-label, Multiple Dose Study to Assess the Pharmacokinetic Profile of Minocycline From FMX-101 Foam (4%) in Male and Female Volunteers
Latest Information Update: 20 May 2021
At a glance
- Drugs Minocycline (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Foamix
Most Recent Events
- 30 Sep 2014 New trial record